Skip to results
Modify your search
NARROW
1-20 of 94
Authors: Lindsey R. Baden
Journal Article
P-1053. Invasive Fusariosis: 5-Year Update from a Single-Center Experience in the Voriconazole Era Open Access
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.1242, https://doi.org/10.1093/ofid/ofae631.1242
Published: 29 January 2025
Journal Article
P-2295. Risk Factors for and Impact of Enteric Gram-negative Infections on Lung Transplant Clinical Outcomes Open Access
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.2448, https://doi.org/10.1093/ofid/ofae631.2448
Published: 29 January 2025
Journal Article
P-2257. Pseudomonas aeruginosa and other Bacterial Infections After Lung Transplant: Risk Factors, Airway Stenosis and other Clinical Outcomes Open Access
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.2410, https://doi.org/10.1093/ofid/ofae631.2410
Published: 29 January 2025
Journal Article
Comparative Outcomes of Babesiosis in Immunocompromised and Nonimmunocompromised Hosts: A Multicenter Cohort Study Get access
Clinical Infectious Diseases, ciaf034, https://doi.org/10.1093/cid/ciaf034
Published: 28 January 2025
Journal Article
EDITOR'S CHOICE
Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE Trial Open Access
Open Forum Infectious Diseases, Volume 11, Issue 12, December 2024, ofae689, https://doi.org/10.1093/ofid/ofae689
Published: 25 November 2024
Journal Article
GUIDELINES
2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis Free
Clinical Infectious Diseases, ciae435, https://doi.org/10.1093/cid/ciae435
Published: 29 October 2024
Journal Article
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial Get access
Clinical Infectious Diseases, Volume 80, Issue 1, 15 January 2025, Pages 223–227, https://doi.org/10.1093/cid/ciae465
Published: 26 September 2024
Journal Article
Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials Get access
The Journal of Infectious Diseases, Volume 230, Issue 6, 15 December 2024, Pages 1384–1389, https://doi.org/10.1093/infdis/jiae400
Published: 03 September 2024
Journal Article
Disseminated Mycobacterium avium Complex Infection Following CD3/CD20 Bispecific Antibody Therapy in a Patient With Follicular Lymphoma Open Access
Open Forum Infectious Diseases, Volume 11, Issue 9, September 2024, ofae460, https://doi.org/10.1093/ofid/ofae460
Published: 08 August 2024
Journal Article
EDITOR'S CHOICE
SARS-CoV-2 Polymerase Chain Reaction Cycle Threshold Trends in Patients Who Are Immunocompromised and Implications for Isolation Precautions Open Access
Open Forum Infectious Diseases, Volume 11, Issue 7, July 2024, ofae367, https://doi.org/10.1093/ofid/ofae367
Published: 29 June 2024
Journal Article
COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials Free
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 364–374, https://doi.org/10.1093/cid/ciae192
Published: 10 April 2024
Journal Article
Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB–Containing Vaccines Open Access
The Journal of Infectious Diseases, Volume 230, Issue 2, 15 August 2024, Pages e279–e286, https://doi.org/10.1093/infdis/jiae067
Published: 13 February 2024
Journal Article
Neuroinvasive Bacillus cereus Infection in Immunocompromised Hosts: Epidemiologic Investigation of 5 Patients With Acute Myeloid Leukemia Open Access
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae048, https://doi.org/10.1093/ofid/ofae048
Published: 25 January 2024
Journal Article
2714. Invasive Fungal Disease in Lung Transplant Recipients: Incidence, Risk Factors, and Outcomes Open Access
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.2325, https://doi.org/10.1093/ofid/ofad500.2325
Published: 27 November 2023
Journal Article
2334. The effectiveness of bivalent COVID-19 booster among patients with hematologic malignancies Open Access
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.1956, https://doi.org/10.1093/ofid/ofad500.1956
Published: 27 November 2023
Journal Article
1939. Who to Boost When: An Analysis of Dosing Interval and Age on COVID-19 Outcomes in the COVE Trial During the Delta and Omicron Waves Open Access
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.2470, https://doi.org/10.1093/ofid/ofad500.2470
Published: 27 November 2023
Journal Article
2707. Complications of Babesiosis in Immunocompromised and Asplenic/Hyposplenic Patients Open Access
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.2318, https://doi.org/10.1093/ofid/ofad500.2318
Published: 27 November 2023
Journal Article
2409. Potential candidates for partial oral treatment in patients with endocarditis at a US center Open Access
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.2029, https://doi.org/10.1093/ofid/ofad500.2029
Published: 27 November 2023
Journal Article
2326. SARS-CoV-2 PCR Cycle Threshold Trends in Immunocompromised Patients and Implications for Isolation Precautions Open Access
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.1948, https://doi.org/10.1093/ofid/ofad500.1948
Published: 27 November 2023
Journal Article
1452. Neuroinvasive Bacillus Cereus Infection Amongst Immunocompromised Patients: Epidemiological Investigation of 5 Cases in Patients with Acute Myeloid Leukemia Open Access
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.1289, https://doi.org/10.1093/ofid/ofad500.1289
Published: 27 November 2023
